Home > Insider Trading > Filing (0001209191-16-153401)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1272354	Ron Cohen	420 Saw Mill River Road Ardsley NY 10502	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-12-01	7,160	$20.74	479,688	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	42,940	Indirect	Beneficial Ownership in Trust

Footnotes

Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.30 to $21.25 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
57,060 shares of Acorda Therapeutics, Inc.'s Common Stock that were distributed to the reporting person on September 8, 2016 by the reporting person's grantor retained annuity trust ("GRAT") are included in the shares reported as held directly by the reporting person. These shares were previously reported as held indirectly through the GRAT.
These shares are held in the GRAT, which was established by the reporting person and of which he is the sole trustee.